Page last updated: 2024-12-10

methyl farnesoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl farnesoate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

methyl farnesoate : A member of the juvenile hormone family of compounds that is the methyl ester of farnesoic acid. Found in several species of crustaceans. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5275508
CHEMBL ID171329
CHEBI ID80535
SCHEMBL ID2023438
MeSH IDM0101251

Synonyms (37)

Synonym
2,6,10-dodecatrienoic acid, 3,7,11-trimethyl-, methyl ester, (2e,6e)-
methyl (2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienoate
2,6,10-dodecatrienoic acid, 3,7,11-trimethyl-, methyl ester
farnesyl methyl ester
methyl (2e,6e)-farnesoate
10485-70-8
methyl farnesoate
(2e,6e)-3,7,11-trimethyl-dodeca-2,6,10-trienoic acid methyl ester
methyl (trans,trans)-farnesoate
(trans,trans)-2,6,10-dodecatrienoic acid, 3,7,11-trimethyl-, methyl ester
2,6,10-dodecatrienoic acid, 3,7,11-trimethyl-, methyl ester, (e,e)-
methyl (2-trans-6-trans)-farnesoate
(2e,6e)-farnesyl methyl ester
methyl (2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrienoate
CHEMBL171329
chebi:80535 ,
3675-00-1
(2e,6e)-methyl 3,7,11-trimethyldodeca-2,6,10-trienoate
methyl 3,7,11-trimethyl-2,6,10-dodecatrienoate
methyl (2-trans,6-trans)-farnesoate
methyl (e,e)-farnesate
methyl farnesate
2-trans-farnesic acid methyl ester
methyl 3,7,11-trimethyl-2e,6e,10-dodecatrienoate
methyl (e,e)-farnesoate
methyl trans,trans-farnesate
methyl trans,trans-farnesoate
methyl (2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrienoate #
methyl trans,trans-farnesenate
NWKXNIPBVLQYAB-VDQVFBMKSA-N
methyl (2e,6e)-farnesate
SCHEMBL2023438
(e,e)-methyl farnesoate
(2e,6e)-methyl3,7,11-trimethyldodeca-2,6,10-trienoate
DTXSID80893654
Q27149580
a methyl farnesoate

Research Excerpts

Overview

Methyl farnesoate (MF) is a de-epoxide form of JH III that regulates many developmental processes in crustaceans, including reproduction, molting, and morphogenesis. It is the crustacean homolog of insect juvenile hormones.

ExcerptReferenceRelevance
"Methyl farnesoate (MF) is a de-epoxide form of JH III that regulates many developmental processes in crustaceans, including reproduction, molting, and morphogenesis, much like JH III in insects."( Potential role of Methoprene-tolerant (Met) in methyl farnesoate-mediated vitellogenesis in the Chinese mitten crab (Eriocheir sinensis).
Chen, T; Han, Y; Huang, J; Huang, M; Jiang, H; Li, X; Su, S; Tao, M; Xie, Q; Xu, R,
)
1.11
"Methyl farnesoate (MF) is an arthropod hormone that plays a key role in the physiology of several arthropods' classes being implicated in biological processes such as molting and reproduction. "( A simple and sensitive approach to quantify methyl farnesoate in whole arthropods by matrix-solid phase dispersion and gas chromatography-mass spectrometry.
Cela, R; Montes, R; Neuparth, T; Quintana, JB; Rodil, R; Santos, MM, 2017
)
2.16
"Methyl farnesoate (MF) is a sesquiterpene compound and the crustacean homolog of insect juvenile hormones. "( Hemolymph Levels of Methyl Farnesoate During Ovarian Development of the Swimming Crab Portunus trituberculatus, and Its Relation to Transcript Levels of HMG-CoA Reductase and Farnesoic Acid O-Methyltransferase.
Cui, X; Li, Y; Qiu, X; Tang, J; Xie, X; Zhu, D, 2015
)
2.18
"Methyl farnesoate is a juvenoid hormone that regulates a variety of processes in crustaceans including male sex determination among daphnids (Branchiopoda, Cladocera). "( Cross communication between signaling pathways: juvenoid hormones modulate ecdysteroid activity in a crustacean.
Leblanc, GA; Mu, X, 2004
)
1.77
"Methyl farnesoate (MF) is an acyclic sesquiterpenoid that has been detected in hemolymph and other tissues of crustaceans and insects. "( Quantification of methyl farnesoate levels in hemolymph by high-performance liquid chromatography.
Borst, DW; Tsukimura, B, 1991
)
2.06

Effects

ExcerptReferenceRelevance
"Methyl farnesoate (MF) has been identified as a juvenile hormone-like compound in crustacea which has central roles in the regulation of development and reproduction. "( A neurohormone regulating both methyl farnesoate synthesis and glucose metabolism in a crustacean.
Hayes, T; Laufer, H; Liu, L; Wang, Y, 1997
)
2.03

Actions

ExcerptReferenceRelevance
"Methyl farnesoate (MF) plays hormonal regulatory roles in crustaceans. "( Epoxidation of juvenile hormone was a key innovation improving insect reproductive fitness.
Areiza, M; DeGennaro, M; Edwards, MJ; Fernandez-Lima, F; Feyereisen, R; Jindra, M; Michalkova, V; Noriega, FG; Nouzova, M; Ramirez, CE; Ruiz, M, 2021
)
2.06

Toxicity

ExcerptReferenceRelevance
" We demonstrate that induction of hemoglobin genes is a well-conserved response to JH even in the ovary, and a potential adverse effect of JH agonist is suppression of vitellogenin gene expression, that might cause reduction of offspring number."( Comparative ovarian microarray analysis of juvenile hormone-responsive genes in water flea Daphnia magna: potential targets for toxicity.
Iguchi, T; Sato, T; Tatarazako, N; Toyota, K; Williams, TD, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
" The in vivo assay showed a positive effect of MF on oocyte growth when injected alone and in combination with 17 beta-estradiol, but not in combination with JHIII or 17 alpha-hydroxyprogesterone."( Effect of methyl farnesoate, alone and in combination with other hormones, on ovarian growth of the red swamp crayfish, Procambarus clarkii, during vitellogenesis.
Fingerman, M; Laufer, H; López Greco, LS; Medesani, DA; Rodríguez, EM, 2002
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
crustacean metaboliteAn animal metabolite produced by arthropods such as crabs, lobsters, crayfish, shrimps and krill.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
juvenile hormoneA family of farnesane sesquiterpenoids that regulate many aspects of insect physiology.
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
fatty acid methyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
juvenile hormone III biosynthesis I017
juvenile hormone III biosynthesis I422

Bioassays (2)

Assay IDTitleYearJournalArticle
AID47224In vitro inhibition of yeast cell growth of candida albicans; No inhibition2002Bioorganic & medicinal chemistry letters, Mar-25, Volume: 12, Issue:6
Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism.
AID47226In vitro inhibition of yeast-to-hypha transition in candida albicans; No inhibition2002Bioorganic & medicinal chemistry letters, Mar-25, Volume: 12, Issue:6
Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (117)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.71)18.7374
1990's21 (17.95)18.2507
2000's41 (35.04)29.6817
2010's45 (38.46)24.3611
2020's8 (6.84)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.55 (24.57)
Research Supply Index4.81 (2.92)
Research Growth Index5.57 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (4.10%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other117 (95.90%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]